Fosun Secures EUR670 Million for Completion of Ageas Sale
Oct 16, 2024 15:36 HKT | |
|
US Rate Cut and China Stimulus Ignite Fosun's Surge
Oct 15, 2024 11:50 HKT | |
|
CanSino Receives Another Strong Boost
Oct 09, 2024 19:29 HKT | |
|
Empower your Heart Health with LAC This World Heart Day!
Oct 09, 2024 17:30 HKT |  |
|
NEFECON Included in 2024 KDIGO Clinical Practice Guidelines
Oct 02, 2024 10:18 HKT | |
|
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
Sep 25, 2024 21:00 HKT |  |
|
DEXIS Digital Ecosystem Expands With Three New Innovations To Streamline and Connect Dental Workflows
Sep 24, 2024 21:30 HKT |  |
|
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT |  |
|
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Sep 17, 2024 20:30 HKT |  |
|
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
Sep 11, 2024 11:34 HKT |  |
|
How Much Do Vegan Diets Improve the Health of Dogs?
Sep 06, 2024 07:00 HKT |  |
|
Celeb-red our Nation's Birthday with LAC!
Aug 31, 2024 09:00 HKT | |
|
Tong Ren Tang Chinese Medicine Announces 2024 Interim Results
Aug 30, 2024 20:50 HKT | |
|
Fosun Pursues Solid Business Development with Predictable Profit
Aug 30, 2024 13:30 HKT | |
|
Hua Medicine Announces 2024 Interim Results
Aug 30, 2024 11:40 HKT | |
|
Yunkang Group's 2024 Interim Revenue Reaches Approximately RMB380 Million
Aug 28, 2024 23:25 HKT |  |
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Aug 24, 2024 08:00 HKT |  |
|
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT |  |
|
Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)
Aug 22, 2024 14:40 HKT | |
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024
Aug 16, 2024 20:47 HKT |  |
|
|
<< Previous
Next >>
|